Wear, Clinical Performance and Computerized Occlusal Evaluation of Hybrid Versus Lithium Disilicates Ceramic CAD/CAM Overlays in Endodontically Treated Molars: A 24-Month Comparative Randomized Clinical Trial

November 11, 2026 updated by: Farah Khaled El Hindawy, Cairo University

This randomized clinical trial aims to compare the clinical performance, wear behavior and relative occlusal force distribution of hybrid ceramic and lithium disilicate CAD/CAM overlays in endodontically treated molars over a 24-month follow up period using Modified USPHS criteria, Geomagic control software and digital occlusal analyzer respectively

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Inclusion criteria of patients: Healthy patients, compliant, having good oral hygiene, willing to commit to the follow up periods, patients without parafunctional habits
  • Inclusion criteria of teeth included: endodontically treated first or second molars, opposing teeth present, consistent root canal fillings, no apical lesion or mobility present, large access cavities with at least one missing wall

Exclusion Criteria:

  • Exclusion criteria of patients: patients having systemic diseases, pregnant females, not willing to commit to the follow up periods, patients with poor oral hygiene, patients having parafunctional habits
  • Exclusion criteria of teeth: endodontically treated anterior or premolar teeth, endodontically treated third molars ,inconsistent root canal filling, presence of periapical lesion or mobility, lack of opposing teeth, conservative access cavities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Endodontically treated molars will be restored using lithium disilicate CAD/CAM overlays

Endodontically treated molars will receive lithium disilicate CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay.

Endodontically treated molars will be prepared to receive lithium disilicate CAD/CAM overlays. Preparation includes cuspal reduction of the buccal and lingual walls 1.5 to 2 mm, removal of all undermined enamel and slight flaring of the cavity walls to 6-10-degree divergence. Following cavity preparation, immediate dentin sealing and cavity optimization followed by scanning and milling of the restoration. Cementation will then follow based on manufacturer instructions using resin cement. Surface treatment including etching of the fitting surface using 9.5% hydrofluoric acid for 20 seconds followed by cleaning for 60 seconds using 37% phosphoric acid gel followed by silane application.

Experimental: Experimental: Endodontically treated molars will be restored using Hybrid Ceramics CAD/CAM overlays

Endodontically treated molars will receive Hybrid ceramics CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay.

Endodontically treated molars will be prepared to receive hybrid ceramics overlays following the concept of morphology driven preparation. This includes cuspal reduction for the buccal and lingual walls, removal of all undermined enamel, slight flaring of the cavity walls to 6-10-degree divergence. After proper cavity preparation, immediate dentin sealing and cavity optimization will be done followed by scanning, milling and finally cementation of the overlay restoration.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wear Assessment
Time Frame: baseline, 12 and 24 months

The volumetric loss of the overlays will be measured by the software Geomagic Control Software

baseline, 12 and 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical performance (Marginal Adaptation)
Time Frame: baseline, 6, 12, 18 and 24 months

Marginal adaptation will be measured by two assessors following Modified USPHS criteria

baseline, 6, 12, 18 and 24 months
Relative Occlusal load distribution
Time Frame: Immediately, 6 and 12 months

relative occlusal load distribution will be measured by digital occlusal analysis system OccluSense

Immediately, 6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 15, 2026

Primary Completion (Estimated)

December 15, 2027

Study Completion (Estimated)

December 15, 2028

Study Registration Dates

First Submitted

November 11, 2026

First Submitted That Met QC Criteria

November 11, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 11, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Cairo CONS 3-7-5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The dataset contains coded but potentially re-identifiable clinical and patient information. Per the study confidentiality plan, data access is restricted to the principal investigator and study supervisors only with records stored securely under password-protected, limited access systems. No plan for sharing individual participant data with external researchers is currently in place.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.